Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography …

A Tawakol, ZA Fayad, R Mogg, A Alon… - Journal of the American …, 2013 - jacc.org
Objectives: The study sought to test whether high-dose statin treatment would result in
greater reductions in plaque inflammation than low-dose statins, using fluorodeoxyglucose …

Update on statin-mediated anti-inflammatory activities in atherosclerosis

F Montecucco, F Mach - Seminars in immunopathology, 2009 - Springer
Anti-inflammatory activities of statins in atherosclerosis have been well documented by both
basic research and clinical studies. Statins have been introduced in the 1980s as 3-hydroxy …

A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling

YC Chen, AV Bui, J Diesch, R Manasseh… - Circulation …, 2013 - Am Heart Assoc
Rationale: The high morbidity/mortality of atherosclerosis is typically precipitated by plaque
rupture and consequent thrombosis. However, research on underlying mechanisms and …

Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia

JM Izquierdo‐Palomares… - Cochrane Database …, 2016 - cochranelibrary.com
Background Elevated levels of total cholesterol and low‐density lipoprotein play an
important role in the development of atheromas and, therefore, in cardiovascular diseases …

Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization …

S Li, S Zhong, K Zeng, Y Luo, F Zhang, X Sun… - Basic research in …, 2010 - Springer
The objective of this study was to evaluate the effects of specific NF-κB inhibitor pyrrolidine
dithiocarbamate (PDTC) on inflammatory response and cardiac function in a rat model of …

The influence of regular walking at different times of day on blood lipids and inflammatory markers in sedentary patients with coronary artery disease

XQ Lian, D Zhao, M Zhu, ZM Wang, W Gao, H Zhao… - Preventive …, 2014 - Elsevier
Objective To examine the influence of walking at different times of day on lipids and
inflammatory markers in sedentary patients with coronary artery disease (CAD). Methods A …

Production of a human metabolite of atorvastatin by bacterial CYP102A1 peroxygenase

THH Nguyen, SJ Yeom, CH Yun - Applied Sciences, 2021 - mdpi.com
Featured Application The peroxygenase activity of CYP102A1 can be used to prepare
atorvastatin drug metabolites and possibly other drugs for biotechnological applications …

Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease

Z Jiang, Z Wu, R Liu, Q Du, X Fu, M Li… - Frontiers in …, 2023 - frontiersin.org
Dyslipidemia due to renal insufficiency is a common complication in patients with chronic
kidney diseases (CKD), and a major risk factor for the development of cardiovascular events …

Statins of high versus low cholesterol‐lowering efficacy and the development of severe renal failure

YH Chung, YC Lee, CH Chang, MS Lin… - … and drug safety, 2013 - Wiley Online Library
Background The objective of this nationwide retrospective cohort study was to examine the
renal outcomes of HMG‐CoA reductase inhibitor (statin) initiators. Methods The patients who …

Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore

S Setia, SSW Fung, DD Waters - Vascular health and risk …, 2015 - Taylor & Francis
Purpose There is an unmet need for strategies to prevent atherosclerotic cardiovascular
disease in Singapore. The main objective of this study was to investigate Singapore …